Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands |
3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
||||||||||
| Income Statement [Abstract] | |||||||||||
| Revenue | $ 1,788,809 | $ 1,664,980 | | ||||||||
| Costs and expenses: | |||||||||||
| Cost of services, exclusive of depreciation and amortization | 1,494,610 | 1,418,819 | |||||||||
| General and administrative | 48,447 | 42,279 | |||||||||
| Depreciation and amortization | 54,069 | 52,425 | |||||||||
| Total costs and expenses | 1,597,126 | 1,513,523 | | ||||||||
| Other operating income | 2,284 | 0 | |||||||||
| Income from operations | 193,967 | 151,457 | | ||||||||
| Other income and expense: | | | | | | | | | | ||
| Equity in earnings of unconsolidated subsidiaries | 10,421 | 8,556 | | | | | | | | | |
| Interest expense | (50,763) | (48,571) | | | | | | | | | |
| Total Other Income Expenses | 40342.0 | 40015.0 | 0.0 | 0.0 | 0.0 | |
|||||
| Total Other Income Expenses | 40342.0 | 40015.0 | 0.0 | 0.0 | 0.0 | |
| ||||
| Total Other Income Expenses | 61184.0 | 57127.0 | 0.0 | 0.0 | 0.0 | |
| ||||
| Total Other Income Expenses | -40342.0 | -40015.0 | 0.0 | 0.0 | 0.0 | |
| ||||
| Total Other Income Expenses | -40342.0 | -40015.0 | 0.0 | 0.0 | 0.0 | |
| ||||
| Total Other Income Expenses | -61184.0 | -57127.0 | 0.0 | 0.0 | 0.0 | |
| ||||
| Total Other Income Expenses | -61184.0 | -57127.0 | 0.0 | 0.0 | 0 | |
| ||||
| Total Other Income Expenses | 61184.0 | 57127.0 | 0.0 | 0 | 0 | |
| ||||
| Total Other Income Expenses | -40342.0 | -40015.0 | 0 | 0 | 0 | |
| ||||
| Income before income taxes | 153,625 | 111,442 | | | |||||||
| Income tax expense | 36,458 | 26,185 | | ||||||||
| Net income | 117,167 | 85,257 | | ||||||||
| Less: Net income attributable to non-controlling interests | 20,270 | 14,452 | |||||||||
| Net income attributable to Select Medical Holdings Corporation | $ 96,897 | $ 70,805 | |||||||||
| Earnings per common share (Note 13): | |||||||||||
| Basic (in dollars per share) | $ 0.75 | $ 0.56 | |||||||||
| Diluted (in dollars per share) | $ 0.75 | $ 0.56 | |||||||||
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|